PTAB

IPR2016-01332

Mylan Pharmaceuticals Inc v. Janssen Oncology Inc

General

Filed

06/30/16

Institution01/10/17

FWD01/17/18

Close01/17/18

StatusFinal Written Decision

OutcomeUnpatentable

USPTOIPR2016-01332

Appeals

Administrative Patent Judges

Judge	Cases	Inst. Rate	FWD Inv. Rate
Jacqueline T Harlow	200+	55%	82%
Jeffrey N Fredman	90+	66%	84%
Kristina M Kalan	500+	61%	73%
Lora M Green	400+	54%	71%
Rama G Elluru	400+	61%	84%

Petitioner

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A
Amneal Pharmaceuticals of New York LLC	L4 A
Amneal Pharmaceuticals LLC	L4 A
Actavis Laboratories FL Inc	L4 C
Teva Pharmaceuticals USA Inc	L4 D
Sun Pharmaceuticals Industries Inc	L3 A
Sun Pharmaceuticals Industries Ltd	L3 A
DR Reddy's Laboratories Ltd	L3 D
DR Reddys Laboratories Inc	L3 D
Hikma Pharmaceuticals LLC	L3 E
West-Ward Pharmaceutical Corp	L3 E

No Parties

Attorney

Name	Ratings
Perkins Coie LLP	L5 A
Brandon M. White	L1 C
Crystal R. Canterbury	-- -- --

No Attorneys

Respondent

Party

Name	Ratings
Janssen Oncology Inc	L4 E

No Parties

Attorney

Name	Ratings
Akin Gump Strauss Hauer & Feld LLP	L4 E
Ruben H. Munoz-Pascua	L4 B
Dianne B. Elderkin	L3 D
Patterson Belknap Webb & Tyler LLP	L1 D
Barbara L. Mullin	L1 C

No Attorneys